1. Home
  2. FEMY vs ACCL Comparison

FEMY vs ACCL Comparison

Compare FEMY & ACCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.38

Market Cap

21.9M

Sector

Health Care

ML Signal

HOLD

ACCL

Acco Group Holdings Limited Ordinary Shares

N/A

Current Price

$1.44

Market Cap

20.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
FEMY
ACCL
Founded
2004
2009
Country
United States
Hong Kong
Employees
N/A
22
Industry
Medical/Dental Instruments
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
21.9M
20.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
FEMY
ACCL
Price
$0.38
$1.44
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$5.50
N/A
AVG Volume (30 Days)
1.0M
11.4K
Earning Date
05-08-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
44.71
N/A
EPS
N/A
N/A
Revenue
$2,293,313.00
N/A
Revenue This Year
$105.16
N/A
Revenue Next Year
$200.23
N/A
P/E Ratio
N/A
$17.13
Revenue Growth
40.77
N/A
52 Week Low
$0.31
$1.23
52 Week High
$1.11
$5.00

Technical Indicators

Market Signals
Indicator
FEMY
ACCL
Relative Strength Index (RSI) 46.47 48.39
Support Level $0.34 $1.32
Resistance Level $0.46 $1.55
Average True Range (ATR) 0.04 0.05
MACD 0.00 -0.00
Stochastic Oscillator 24.29 60.72

Price Performance

Historical Comparison
FEMY
ACCL

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

Share on Social Networks: